Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pseudomonas pneumonia

A 31-year-old woman with a Pseudomonas pneumonia was given intravenous ciprofloxacin 400 mg 12-hourly, tobramycin 400 mg/day, and piperacillin 4 g 6-hourly (37). Three days after the initial administration of the intravenous antibiotics, she developed a morbilliform eruption on the sun-exposed areas of her chest, back, and arms, corresponding to sites of intense sunburn that had occurred a month before. [Pg.3438]

Acute inflammation significantly alters CYP expression and activity. Inflammatory cytokines such as TNFa suppress hepatic CYP expression at the mRNA level [235]. CYP2J4 protein expression and epoxygenase activity are reduced in a rat model of Pseudomonas pneumonia [236]. Lipopolysaccharide acutely suppresses murine CYP2C44 and CYP2J5 expression and activity, while resolution of inflammation correlates with the restoration of epoxygenase expression [237]. [Pg.893]

Yaghi A, Bradbury JA, Zeldin DC, Mehta S, Bend JR, McCormack DG (2003) Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. Am J Physiol Lung Cell Mol Physiol 285 L1099-L1105... [Pg.904]

Sadikot RT, Zeng H, Yuli FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM, Blackwell TS, Christman JW. p47(phox) deficiency impairs NF-kappaB activation and host defense in Pseudomonas pneumonia. J Immunol 2004 172 1801-1808. [Pg.111]

Kanamydn A Kanamycin B Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa... [Pg.188]

Meropenem (Merrem IV) inhibits syndiesis of die bacterial cell wall and causes die deadi of susceptible cells. This drug is used for intra-abdominal infections caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and odier susceptible organisms Meropenem also is effective against bacterial meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Hemophilus influenzae. [Pg.102]

Oxacillin-resistant S. aureus, Pseudomonas aeruginosa, Acinetobacter spp., Enterobacter spp., and Klebsiella pneumoniae... [Pg.127]

Empirical coverage against 5. pneumoniae, L. pneumophila, H. influenzae, enteric GNB, 5. aureus Adult inpatient ICU (Pseudomonas is a concern)... [Pg.1056]

Bacterial pneumonia (commonly Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, and Staphylococcus aureus)... [Pg.1256]

Nosocomial pneumonia Gram-negative bacilli (such as K pneumoniae, Enterobacter spp.. Pseudomonas aeruginosa), 5. aureus Pi peraci 11 i n-tazo bacta rr carbapenem,e or extended-speclrum cephalosporin plus aminoglycoside, fluoroquinolone ... [Pg.487]

The urinary pathogens in complicated or nosocomial infections may include E. coli, which accounts for less than 50% of these infections, Proteus spp., Klebsiella pneumoniae, Enterobacter spp., Pseudomonas aeruginosa, staphylococci, and enterococci. Candida spp. have become common causes of urinary infection in the critically ill and chronically catheterized patient. [Pg.558]

Complicated coli Proteus mirabiiis Klebisella pneumoniae Pseudomonas aeruginosa Enterococcus faecalis 1. Quinolone x 14 days (B, III)0 2. Extended-spectrum penicillin plus aminoglycoside (B, III)0 Severity of illness will determine duration of IV therapy culture results should direct therapy Oral therapy may complete 14 days of therapy... [Pg.562]

Mainly [l,2,4]triazolo[3,4-3][l,3,4]thiadiazoles 139 have been tested for their activity against various bacteria like Escherichia coli, Staphylococcus aureus, Candida albicans, Pseudomonas aeruginosa, Klebsiella pneumoniae, or Bacillus subtillis (Table 4). [Pg.345]

Standard and the isolated strains of the following bacteria, namely Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 10145), Proteus mirabilis (ATCC 7002), Klebsiella pneumoniae (RSKK 574), Acinetobacter baumannii (RSKK 02026), Staphylococcus aureus (ATCC 25923), and Enterococcus faecalis (ATCC 29212) for determination of antibacterial activity, along with standard strains of Candida albicans (ATCC 10231) and C. parapsilosis (ATCC 22019) were used for determination of antifungal activity. [Pg.99]

Exotoxin A diphtheriae Pseudomonas aeruginosa AB Elongation Factor-2 Inhibition of protein synthesis Pneumonia... [Pg.152]

See other pages where Pseudomonas pneumonia is mentioned: [Pg.259]    [Pg.274]    [Pg.3]    [Pg.259]    [Pg.274]    [Pg.3]    [Pg.303]    [Pg.27]    [Pg.39]    [Pg.62]    [Pg.291]    [Pg.292]    [Pg.294]    [Pg.28]    [Pg.425]    [Pg.430]    [Pg.585]    [Pg.128]    [Pg.113]    [Pg.240]    [Pg.1035]    [Pg.1050]    [Pg.1055]    [Pg.1057]    [Pg.1062]    [Pg.1131]    [Pg.1152]    [Pg.175]    [Pg.190]    [Pg.489]    [Pg.500]    [Pg.350]   


SEARCH



Pneumonia

Pseudomonas aeruginosa infections pneumonia

© 2024 chempedia.info